NA vs VIOT
Nano Labs Ltd. and Viomi Technology Co. Ltd., side by side — 6 fiscal years reported in CNY, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | NA | VIOT |
|---|---|---|
| Revenue | CNY 27.0M | CNY 2.4B |
| Net income | CNY 135.5M | CNY 141.9M |
| Gross margin | −147.3% | 25.3% |
| Net margin | 466.4% | 5.8% |
| Return on equity | 27.7% | 9.6% |
| Diluted EPS | CNY 6.82 | CNY 0.67 |
| Dividend / share | — | — |
| Payout ratio | — | — |
| Free cash flow | CNY -108.3M | CNY 113.5M |
| Equity | CNY 748.3M | CNY 1.5B |
| Net debt / equity | 0.23× | −0.48× |
| Current ratio | 2.09× | 2.60× |
| Revenue CAGR 5y | 66.2% | −16.1% |
| Profit CAGR 5y | — | — |
VIOT bills 89.9× the revenue of NA, and NA keeps more of each dollar of revenue as profit (466.4% against 5.8%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Revenue by year
6 years side by side
| Fiscal year | NA | VIOT |
|---|---|---|
| FY2025 | CNY 27.0M | CNY 2.4B |
| FY2024 | CNY 40.6M | CNY 2.1B |
| FY2023 | CNY 78.3M | CNY 1.6B |
| FY2022 | CNY 983.2M | CNY 1.8B |
| FY2021 | CNY 39.4M | CNY 5.3B |
| FY2020 | CNY 2.1M | CNY 5.8B |
Net income by year
Bottom line
| Fiscal year | NA | VIOT |
|---|---|---|
| FY2025 | CNY 135.5M | CNY 141.9M |
| FY2024 | CNY -113.2M | CNY 62.3M |
| FY2023 | CNY -252.8M | CNY -89.3M |
| FY2022 | CNY 31.1M | CNY -282.6M |
| FY2021 | CNY -174.9M | CNY 88.6M |
| FY2020 | CNY -37.7M | CNY 173.3M |
More in this industry